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Background: This study evaluated the beneﬁ  ts and safety of a multimodal pain control protocol, which included a periarticular 
injection of local anesthetics, in patients undergoing total hip arthroplasty.
Methods: Between March 2006 and March 2007, 60 patients undergoing unilateral total hip arthroplasty were randomized 
to undergo either a multimodal pain control protocol or a conventional pain control protocol. The following parameters were 
compared: the preoperative and postoperative visual analogue scales (VAS), hospital stay, operative time, postoperative 
rehabilitation, additional painkiller consumption, and complication rates.
Results: There was no difference between the groups in terms of diagnosis, age, gender, and BMI. Although both groups had 
similar VAS scores in the preoperative period and on the ﬁ  fth postoperative day, there was a signiﬁ  cant difference between the 
groups over the four-day period after surgery. There were no differences in the hospital stay, operative time, additional painkiller 
consumption, or complication rate between the groups. The average time for comfortable crutch ambulation was 2.8 days in the 
multimodal pain control protocol group and 5.3 days in the control group.
Conclusions: The multimodal pain control protocol can signiﬁ  cantly reduce the level of postoperative pain and improve patients’ 
satisfaction, with no apparent risks, after total hip arthroplasty.
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and nerve blocks cannot be avoided.
3,10-13) Therefore, in 
an attempt to provide effective pain management and 
reduce these drug-related complications, we developed a 
multimodal pain control protocol using a mixture of drugs 
with diff  erent mechanisms of action in patients undergoing 
THA and examined its effi   cacy.
METHODS
Of the patients who underwent primary THA performed 
in our hospital between March 2006 and March 2007, 
60 patients were enrolled in this study. The exclusion 
criteria included those with severe psychiatric disorders, a 
history of drug addiction, allergy to any study medication, 
cerebral infarction or a severe neurological lesion, and 
severe heart or renal disease. The study population 
was divided randomly into 2 groups: Group I (n=30) 
Total hip arthroplasty (THA) is performed for pain relief, 
normal joint motion, and a deformity correction of the 
hip. However, its effi   cacy is oft  en limited by perioperative   
pain management.
1-5) In some studies, proper pain control 
is not obtained in more than half of patients, who undergo 
THA.
6,7) Failure of postoperative pain management 
directly affects rehabilitation of patients. Many authors 
have suggested a variety of solutions for postoperative 
pain and demonstrated their remarkable efficacy, but the 
complications associated with the overuse of narcotics
8,9) 156
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received our multimodal pain management including 
periarticular injections of multimodal drugs; and group II 
received only standard pain management. The results of 
the two protocols were compared prospectively in terms 
of the level of pain measured before and until 5 days 
after surgery, hospital stay, operative time, postoperative 
rehabilitation, postoperative consumption of parenteral 
pain medication, and complications of pain medications, 
such as nausea (Table 1). 
Th   e mean age of the patients was 53.1 years (range, 
31 to 76 years). Th   ere were 36 males and 24 females. Th  e 
presumed cause was osteonecrosis of the femoral head in 
43 cases, acetabular dysplasia with advanced osteoarthritis 
in 8 cases, sequelae of Legg-Calvé-Perthes’ disease in 5 
cases, and sequelae of pyogenic arthritis in 4 cases. Th  ere 
were no diff  erences in gender, age, presumed cause, height, 
weight, and BMI between the two groups (Table 2).
Preemptive analgesia was performed for central 
sensitization 2 hours before surgery in group I while 
it was not applied in group II. In all cases, surgery was 
performed under general anesthesia. In group I, epidural 
anesthesia and a periarticular injection of multimodal 
drugs were also performed intraoperatively. In group 
II, intravenous patient-controlled analgesia was used 
postoperatively. Isoflurane was used for inhalational 
anesthesia. For intravenous patient-controlled analgesia, 
diff  erent doses of morphine were administered depending 
on the patient’s age, height, and weight. All procedures 
were carried out by the same surgeon using a minimally 
invasive anterolateral approach according to a standard 
protocol. The periarticular injection (90 ml) contained 5 
mg of morphine HCl, 40 mg of methylprednisolone, and 
6.8 mg of ropivacaine dissolved in 70 ml of 0.9% normal 
saline. One-third (30 ml) of the mixture was injected 
before inserting the prosthesis, another third (30 ml) was 
administered immediately before reducing the prosthesis 
into the synovial sheath, joint capsule, deep fascia, and 
damaged muscle layer, and the remainder (30 ml) was 
infused into the subcutaneous tissues and adipose layer 
(Table 3). For postoperative pain management, all patients 
were given regular oral nonsteroidal anti-inflammatory 
drugs (NSAIDs) and parenteral analgesics were used when 
needed. In group I (multimodal pain control group), more 
than two analgesics with different mechanisms of action 
were administered orally for postoperative pain control 
until 2 days aft  er surgery (Table 4). 
Th   e pain was assessed by the patients using a 100 mm 
Experimental group Control group
Preoperative 
 period
Preemptive protocol (Table 4)
Intraoperative 
 period
Minimally invasive surgery
General + epidural anesthesia
Periarticular injection (Table 3)
Minimally invasive 
 surgery
 General anesthesia
Postoperative 
 period
Postoperative protocol (Table 4)
NSAIDs
Analgesic injection if needed
IV PCA
NSAIDs
Analgesic injection 
 if needed
IV PCA: Intravenous patient-controlled analgesia, NSAIDs: Nonsteroidal anti- 
inﬂ  ammatory drugs.
  Table 1. Schema of This Study
Experimental group Control group p-value
Average age* (year) 51.3 ± 10.6 54.8 ± 15.8 0.317
Gender (male : female) 19 : 11 17 : 13 0.598
Average body mass index* 23.1 ± 3.9 22.2 ± 2.8 0.326
Average hospital stay* (day) 18.77 ± 5.98 20.60 ± 6.34 0.190
Presumed causes (no.)
    ONFH 24 19 0.446
    Acetabular dysplasia with advanced OA   3   5 0.480
    LCP sequelae   2   3 0.655
Pyogenic arthritis sequelae   1   3 0.317
*All values are presented as the mean ± standard deviation.
ONFH: Osteonecrosis of femoral head, OA: Osteoarthritis, LCP: Legg-Calvé-Perthes disease.
  Table 2. Demographic Data157
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visual analogue scale (VAS; 0 mm = no pain, 100 mm = 
unbearable pain). Th   ey were asked to make measurements 
at a specifi  c time before surgery, immediately aft  er sur  gery, 
and from the 1st to the 5th postoperative day. Depend-
ing on the level of pain, the patients were assigned to 
different postoperative rehabilitation programs ranging 
from quadriceps strengthening to straight leg raising. 
Th   e days on which comfortable ambulation was achieved 
with the aid of crutches were also recorded. The doses 
of additional parenteral analgesics prescribed on an as-
needed basis were assessed until the 5th postoperative day. 
Th   e occurrence of complications such as nausea, vomiting, 
and surgical site infection was also investigated. Statistical 
analysis was performed suing a Student’s t-test and Chi-
square test. Statistical signifi  cance was defi  ned as p < 0.05.
RESULTS
Visual Analogue Scale
The average VAS score in groups I and II was 2.3 and 
2.6 preoperatively, indicating no significant difference 
between the two groups (p = 0.263). Th   e mean VAS scores 
measured every day at a specific time from immediately 
after surgery until the 4th postoperative day were 
respectively, 3.0, 2.0, 2.1, 2.7, and 2.4 in group I and 7.6, 
4.9, 3.6, 3.6, and 3.3 in group II. Signifi  cant pain relief was 
noted in group I (p < 0.05). Th   e mean VAS score obtained 
on the 5th postoperative day was slightly lower in group 
I than in group II (2.1 and 2.7, respectively), but there 
was no signifi  cant diff  erence between the two groups (p = 
0.275) (Fig. 1).
Hospital stay and Operative Time
The mean hospital stay was 18.8 ± 6.0 days in group I 
using our multimodal pain control protocol and 20.6 ± 
6.3 days in group II. There was no significant difference 
between the two groups (p = 0.190). Th   e mean operative 
time from the skin incision to closure was 114.5 minutes 
(range, 60 to 150 minutes) in group I with periarticular 
injections and 110.1 minutes (range, 60 to 150 minutes) 
in group II. This shows that the periarticular injections 
extended the surgery time slightly but the diff  erence is not 
statistically signifi  cant (p = 0.442).
 
Postoperative Rehabilitation
The average time required for the patients to be able to 
perform straight leg raising excercises without pain and 
comfortable ambulation with the aid of crutches was 2.8 
Preemptive pain management protocol (2 hours before surgery)
If older than 65 years
    Oxycodone CR 10 mg orally, Celecoxib 400 mg orally
If younger than 65 years
    Oxycodone CR 10 mg orally, Acetaminophen 650 mg orally
Postoperative pain management protocol
Oxycodone CR 5 mg/10 mg q 12 hours orally for 48 hours*
Acetaminophen 650 mg q 12 hours orally for 48 hours*
*Use alternately.
  Table 4. Components and Protocol for Preemptive and Postoperative 
Pain Control in the Experimental Group
Fig. 1. Summary of the visual analogue scale (VAS) for pain. 
  Imm. PO: Immediate postoperatively, POD1, POD2, POD3, POD4, and 
POD5: one, two, three, four, and ﬁ  ve days postoperatively.
Components of periarticular injection
1. Morphine HCl 5 mg
2. Methylprednisolone acetate 40 mg
3. Ropivacaine 6.8 mg
4. Dilute with 0.9% normal saline to  total volume of 90 cc
Injection sites
Before irrigation and closure
    Capsule
    Iliopsoas tendon and insertion site
    Abductors
    Fascia lata
    Synovium
After fascial closure
    Fat layer
    Subcutaneous tissue
  Table 3. Components and Injection Sites of Intraoperative Periarticular 
      Injection in the Experimental Group158
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days and 5.3 days in groups I and II, respectively. This 
indicates that, group I with our multimodal pain control 
protocol showed more rapid recovery than group II (p = 
0.000).
Additional Consumption of Analgesics and 
Complication Rate
The two groups consumed a similar level of additional 
analgesics as a supplement to  the regular intake of 
NSAIDs prescribed until the 5th postoperative day, 2.5 and 
3.1 times in group I and II, respectively; (p = 0.236). Th  ere 
were 9 and 12 medication-related complications, such 
as nausea and vomiting, in groups I and II, respectively, 
showing no signifi  cant diff  erence (p = 0.725). Th  ere  were 
no cases of wound infection or a delay in wound healing 
due to the extended period of drainage.
DISCUSSION
As a refl  ection of the growing interest in pain, the Amer-
ican Pain Society designated pain as the 5th vital sign 
and stated that the success or failure of an operation is 
determined by postoperative pain management. Pain is a 
unique experience for each individual and the responses 
to postoperative pain management vary. Many authors 
developed variety of methods, such as continuous epidural 
anesthesia, injection of analgesics into the joint cavity, 
intravenous patient-controlled analgesia, and nerve 
blocks
12,14-16) and described their effi   cacy in postoperative 
pain management. Some authors reported that a single 
pain management method had only limited effects.
1-5) In 
addition, various complications related to medications, 
such as nausea, vomiting, respiratory failure, hypotension, 
paralysis and dysuria, were also reported.
10-13,17-19)
Pain is a sensation perceived through several 
steps after tissue trauma: transduction, transmission, 
modulation in the spinal cord, and perception in the 
cerebral cortex. Multimodal pain control protocols 
using a combination of analgesic regimens with diff  erent 
mechanisms of action have been designed to promote 
eff  ective pain control and reduce medication-related side 
eff  ects.
16,20) Th   e protocols also include preoperative patient 
education, proper anesthesia, and minimally invasive 
surgery for the least tissue damage. There has been 
increasing interest in multimodal pain control protocols 
and several studies have reported satisfying results.
20-23) 
In this study, the multimodal pain control protocol also 
reduced significantly the level of pain from immediately 
after surgery to the 4th postoperative day, particularly 
to the 2nd postoperative day. Unfortunately, the VAS 
score was approximately 3 (bearable pain) since the 3rd 
postoperative day, which is statistically but not clinically 
significant. This is believed to be the reason why there 
was no diff  erence in the dose of postoperative parenteral 
analgesia between the two groups. 
Our multimodal pain control protocol can be char-
acterized by the use of preemptive analgesia, epidural 
anesthesia and a periarticular injection during surgery, and 
various medications aft  er surgery. Reports have shown that 
preemptive analgesia prevents central sensitization and 
reduces the level of postoperative pain.
24-26) Parvataneni et 
al.
27) reported that a periarticular injection of multimodal 
drugs is one of the most important procedures in 
multimodal pain control protocol. According to Vendittoli 
et al.,
28) an injection into injured or stretched nerves or 
tissues under the guidance of a surgeon can lead to a 
direct block of the nerves. Th   e postoperative pain control 
procedures using variety of pain medications is also an 
inevitable element in maintaining the efficacy of pre- 
and intraoperative pain control procedures. The major 
medications used in this study included oxycodone CR, 
COX-2 selective inhibitor, acetaminophen, morphine HCl, 
methylprednisolone (Depo-Medrol), and ropivacaine. 
Among them, Oxycodone CR was used to activate the mu-
opioid receptors to inhibit the release of pain transmitters. 
The COX-2 selective inhibitor was used as a basic pain 
medication and an anti-inflammatory agent inhibiting 
isoenzyme and prostaglandin production. Morphine 
HCl, methylprednisolone, and ropivacaine, which were 
components of the periarticular injection cocktail, 
activated directly the mu-opioid receptor near the surgical 
site inhibiting the local inflammatory response and 
relieving the pain by preventing the production of pain 
transmitters. Th   e concomitant use of these drugs resulted 
in effective pain management by disrupting the various 
pathways of pain.
However, the use of epidural anesthesia, which is 
an invasive procedure, and the dditional expenses should 
be taken into consideration when applying a multimodal 
pain control protocol. In addition, although there were no 
complications associated with periarticular injections in this 
study, Vendittoli et al.
28) warned of the risk of the  plasma 
concentration of local anesthetics, which they observed in 
some of their study population. 
According to Burns et al.,
29) various factors such as age, 
gender, cultural background, education, and expectation of 
surgery aff  ect the awareness of pain aft  er surgery. Vendittoli 
et al.
28) reported that the use of a multimodal pain control 
protocol contributed  reduction in the use of narcotics. 
Unfortunately, due to the small study population, this study 159
Lee et al. Multimodal Pain Control in Total Hip Arthroplasty
Clinics in Orthopedic Surgery • Vol. 1, No. 3, 2009 • www.ecios.org
REFERENCES
1.  Albert TJ, Cohn JC, Rothman JS, Springstead J, Rothman RH, 
Booth RE Jr. Patient-controlled analgesia in a postoperative 
total joint arthroplasty population. J Arthroplasty. 1991;6 
Suppl:S23-8. 
2.  Forst J, Wolff   S, Th   amm P, Forst R. Pain therapy following 
joint replacement: a randomized study of patient-controlled 
analgesia versus conventional pain therapy. Arch Orthop 
Trauma Surg. 1999;119(5-6):267-70. 
3.  Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur 
JM. Eff  ects of intravenous patient-controlled analgesia with 
morphine, continuous epidural analgesia, and continuous 
three-in-one block on postoperative pain and knee reha-
bilitation after unilateral total knee arthroplasty. Anesth 
Analg. 1998;87(1):88-92. 
4.  Strassels SA, Chen C, Carr DB. Postoperative analgesia: eco-
nomics, resource use, and patient satisfaction in an urban 
teaching hospital. Anesth Analg. 2002;94(1):130-7.
5.  Viscusi ER. Emerging techniques in the treatment of 
postoperative pain. Am J Health Syst Pharm. 2004;61 Suppl 
1:S11-4. 
6.  Filos KS, Lehmann KA. Current concepts and practice in 
postoperative pain management: need for a change? Eur 
Surg Res. 1999;31(2):97-107. 
7.  Follin SL, Charland SL. Acute pain management: operative 
or medical procedures and trauma. Ann Pharmacother. 
1997;31(9):1068-76. 
8.  Mahoney OM, Noble PC, Davidson J, Tullos HS. Th  e  eff  ect 
of continuous epidural analgesia on postoperative pain, 
rehabilitation, and duration of hospitalization in total knee 
arthroplasty. Clin Orthop Relat Res. 1990;(260):30-7. 
9.  Pettine KA, Wedel DJ, Cabanela ME, Weeks JL. The use 
of epidural bupivacaine following total knee arthroplasty. 
Orthop Rev. 1989;18(8):894-901. 
10.  Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rub-
enovitch J, d'Athis F. Effects of perioperative analgesic 
technique on the surgical outcome and duration of reha-
bilitation after major knee surgery. Anesthesiology. 
1999;91(1):8-15. 
11.  Horlocker TT, Cabanela ME, Wedel DJ. Does postoperative 
epidural analgesia increase the risk of peroneal nerve palsy 
aft  er total knee arthroplasty? Anesth Analg. 1994;79(3):495-
500. 
12.  Horlocker TT, Hebl JR, Kinney MA, Cabanela ME. Opi-
oid-free analgesia following total knee arthroplasty: a 
multimodal approach using continuous lumbar plexus 
(psoas compartment) block, acetaminophen, and ketorolac. 
Reg Anesth Pain Med. 2002;27(1):105-8. 
13.  Horlocker TT, Wedel DJ. Neuraxial block and low-molec-
ular-weight heparin: balancing perioperative analgesia and 
thromboprophylaxis. Reg Anesth Pain Med.1998;23(6 Suppl 
2):164-77. 
14.  Mollmann M, Cord S, Holst D, Auf der Landwehr U. 
Con  tinuous spinal anaesthesia or continuous epidural 
anaesthesia for post-operative pain control after hip re-
placement? Eur J Anaesthesiol. 1999;16(7):454-61. 
15.  Niemi L, Pitkanen M, Dunkel P, Laakso E, Rosenberg PH. 
Evaluation of the usefulness of intrathecal bupivacaine 
infusion for analgesia aft  er hip and knee arthroplasty. Br J 
Anaesth. 1996;77(4):544-5.
16. Reuben  SS, Sklar J. Pain management in patients who 
undergo outpatient arthroscopic surgery of the knee. J Bone 
Joint Surg Am. 2000;82(12):1754-66. 
17.  Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, 
Wu CL. Effi   cacy of postoperative epidural analgesia: a meta-
analysis. JAMA. 2003;290(18):2455-63. 
18.  Burstal R, Wegener F, Hayes C, Lantry G. Subcutaneous 
tunnelling of epidural catheters for postoperative analgesia 
to prevent accidental dislodgement: a randomized con-
trolled trial. Anaesth Intensive Care. 1998;26(2):147-51.
19.  Ready LB. Acute pain: lessons learned from 25,000 patients. 
Reg Anesth Pain Med. 1999;24(6):499-505. 
20.  Skinner HB. Multimodal acute pain management. Am J 
Orthop. 2004;33(5 Suppl):5-9. 
21.  Hartrick CT. Multimodal postoperative pain management. 
Am J Health Syst Pharm. 2004;61 Suppl 1:S4-10. 
22.  Sinatra RS, Torres J, Bustos AM. Pain management after 
major orthopaedic surgery: current strategies and new 
concepts. J Am Acad Orthop Surg. 2002;10(2):117-29. 
23.  Viscusi ER. Emerging techniques for postoperative analgesia 
could not examine the association between these factors. 
More studies on the relationship between pain control 
protocols and narcotics in Koreans will be needed to increase 
the effi   cacy of pain management in Korea.
In conclusion, multimodal pain control protocols 
using a mixture of more than two drugs with different 
mechanisms of actions effectively improve the patients’ 
satisfaction by providing early postoperative pain 
relief without increasing the risk of complications and 
prolonging the surgery time in patients undergoing THA.160
Lee et al. Multimodal Pain Control in Total Hip Arthroplasty
Clinics in Orthopedic Surgery • Vol. 1, No. 3, 2009 • www.ecios.org
in orthopedic surgery. Am J Orthop. 2004;33(5 Suppl):13-6. 
24.  Heard SO, Edwards WT, Ferrari D, et al. Analgesic eff  ect of 
intraarticular bupivacaine or morphine after arthroscopic 
knee surgery: a randomized, prospective, double-blind 
study. Anesth Analg. 1992;74(6):822-6. 
25.  Ringrose NH, Cross MJ. Femoral nerve block in knee joint 
surgery. Am J Sports Med. 1984;12(5):398-402. 
26.  Woolf CJ, Chong MS. Preemptive analgesia: treating post-
operative pain by preventing the establishment of central 
sensitization. Anesth Analg. 1993;77(2):362-79.
27.  Parvataneni HK, Ranawat AS, Ranawat CS. Th   e use of local 
periarticular injections in the management of postoperative 
pain after total hip and knee replacement: a multimodal 
approach. Instr Course Lect. 2007;56:125-31. 
28.  Vendittoli PA, Makinen P, Drolet P, et al. A multimodal 
analgesia protocol for total knee arthroplasty: a randomized, 
controlled study. J Bone Joint Surg Am. 2006;88(2):282-9.
29.  Burns JW, Hodsman NB, McLintock TT, Gillies GW, Kenny 
GN, McArdle CS. The influence of patient characteristics 
on the requirements for postoperative analgesia:  a reassess-
ment using patient-controlled analgesia. Anaesthesia. 
1989;44(1):2-6.